Griffin Asset Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
SFS
Griffin Asset Management's SBIO Position: Q1 2026 in Review
Griffin Asset Management held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q1 2026 at 30,699 shares worth $1.61M. The position accounts for 0.18% of the portfolio, ranked #108.
Griffin Asset Management first reported a position in SBIO in Q4 2018 and has held it in 25 quarters since. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.
- Griffin Asset Management held 30,699 shares of ALPS Medical Breakthroughs ETF worth $1.61M as of Q1 2026.
- Griffin Asset Management left its ALPS Medical Breakthroughs ETF share count unchanged in Q1 2026.
- ALPS Medical Breakthroughs ETF made up 0.18% of Griffin Asset Management's portfolio in Q1 2026, its #108 holding.
- Griffin Asset Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2018 and has held it in 25 quarters since.
- 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.
Based on Griffin Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.